Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  NATIONAL STOCK EXCHANGE OF INDIA  >  Vimta Labs Ltd    VIMTALABS   INE579C01029

VIMTA LABS LTD (VIMTALABS)
My previous session
Most popular
End-of-day quote. End-of-day quote  - 01/18
280.3 INR   -1.74%
 SummaryQuotesChartsNewsCalendarCompanyFinancials 
Quotes 5-day view   End-of-day quote. End-of-day quote National Stock Exchange O…
01/14/2019 01/15/2019 01/16/2019 01/17/2019 01/18/2019 Date
294.15(c) 300.05(c) 290.75(c) 285.25(c) 280.3 Last
66 274 131 379 43 063 30 938 22 132 Volume
-2.13% +2.01% -3.10% -1.89% -1.74% Change
More quotes
Company
Vimta Labs Limited is engaged in the business of contract research and testing services. The Company provides services of testing and contract research in the fields of clinical and pre-clinical studies, clinical reference, analytical testing, advanced molecular biology and environmental studies.... 
More about the company
Latest news on VIMTA LABS LTD
2018VIMTA LABS : Quarterly results - vimta labs limited
AQ
2018VIMTA LABS : Trailing twelve month results - vimta labs limited
AQ
2018SHARE HOLDING PATTERN AND MARKET RE : - vimta labs limited
AQ
2018VIMTA LABS LTD : Ex-dividend day for final dividend
FA
2018VIMTA LABS : Trailing twelve month results - vimta labs limited
AQ
2018VIMTA LABS : Quarterly results - vimta labs limited
AQ
2018VIMTA LABS : Quarterly results - vimta labs limited
AQ
2018VIMTA LABS : Trailing twelve month results - vimta labs limited
AQ
2018VIMTA LABS : standalone net profit rises 97.68% in the December 2017 quarter
AQ
2018VIMTA LABS LIMITED : - Trading Window
AQ
More news
Sector news : Bio Diagnostics & Testing
01/18Samsung Bioepis biosimilar to Roche's Herceptin wins FDA nod
RE
01/08NEKTAR THERAPEUTICS : Shares Up Tuesday as Gilead Collaboration Announced -- Mar..
DJ
01/08GlaxoSmithKline to look for early-stage assets - CEO
RE
01/08Lilly's Deal Boosts Its Cancer Arsenal -- WSJ
DJ
01/07Eli Lilly to Buy Loxo Oncology in $8 Billion Deal -- 5th Update
DJ
More sector news : Bio Diagnostics & Testing
Chart VIMTA LABS LTD
Duration : Period :
Vimta Labs Ltd Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends VIMTA LABS LTD
Short TermMid-TermLong Term
TrendsNeutralNeutralBullish
Managers
NameTitle
Harita Vasireddi Managing Director & Executive Director
Sivalinga Prasad Vasireddi Non-Executive Chairman
Harriman Vungal Executive Director & Executive Director-Operations
Amit Pathak Chief Financial Officer
Sireesh Chandra Vungal Group Vice President-Information Technology
Sector and Competitors
1st jan.Capitalization (M$)
VIMTA LABS LTD-10.75%87
GENSCRIPT BIOTECH CORP11.62%2 743
MIRACA HOLDINGS INC.6.33%1 351
IOVANCE BIOTHERAPEUTICS INC6.44%1 160
INVITAE CORP--.--%1 115
CAREDX INC-2.07%1 014